Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SINGAPORE – French pharmaceutical company, Sanofi has begun construction on the first of two so-called Evolutive Vaccine Facilities (EVFs) it is constructing with a total investment of 900 million euros…
Read More
INDIA –Sanofi India (SIL) announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals. He will move from his…
Read More
FRANCE – Sanofi and IGM Biosciences have formed an exclusive global partnership to create, develop, manufacture, and commercialize immunoglobulin M (IgM) antibody agonists for oncology, immunology, and inflammation targets. The…
Read More
FRANCE – Sanofi and Blackstone Life Sciences have announced a risk-sharing agreement in which Blackstone Life Sciences will contribute up to €300 million (US$330 million) to fund the development of…
Read More
FRANCE – Sanofi has been named one of the most sustainable companies in an ESG (Environment, Social, Governance) evaluation conducted by Standard & Poor’s Global Ratings (S&P). Sanofi received an…
Read More
USA –DarioHealth Corp., a global digital therapeutics (DTx) provider, announced a US$30 million multi-year strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, US $30 million agreement…
Read More
FRANCE – China’s Adagene Inc, a Nasdaq-listed innovative biopharmaceutical company focused on the discovery and development of antibody-based novel cancer immunotherapy has announced a collaboration and signed an exclusive license…
Read More
USA – Pfizer Inc. and Valneva SE, have announced additional positive Phase 2 data for their Lyme disease vaccine candidate, VLA15, the only Lyme disease vaccine candidate currently in clinical…
Read More
FRANCE – The US FDA has approved Enjaymo (sutimlimab-jome) infusion to reduce the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold…
Read More
FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their application to the US Food and Drug Administration to expand the use of their anti-cancer drug Libtayo in…
Read More